• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织细胞增多症X的预后因素。

Prognostic factors in histiocytosis X.

作者信息

Lahey M E

出版信息

Am J Pediatr Hematol Oncol. 1981 Spring;3(1):57-60.

PMID:6972178
Abstract

It is now clear that the prognosis in children with histiocytosis X has improved considerable over the past few years. To be sure, patients with solitary lesions have an excellent prognosis. Whereas the outlook for patients with significant visceral involvement is not as good as those with bone lesions only, the outlook is by no means hopeless, as was once thought. A number of prognostic factors have been reviewed here. The most significant of these factors at the present time would appear to be age of onset of the disease, extent of involvement, the rapidity of progression of the disease, and, in particular, the presence or absence of dysfunction of such crucial organ systems as liver, lung, and hemopoietic system. Further studies of the significance of histologic features and immunologic findings are clearly needed to further our understanding of this disorder.

摘要

现在已经清楚,在过去几年里,朗格汉斯细胞组织细胞增多症患儿的预后有了显著改善。诚然,患有孤立性病变的患者预后极佳。虽然有明显内脏受累的患者的前景不如仅患有骨病变的患者,但绝不像曾经认为的那样毫无希望。这里回顾了一些预后因素。目前这些因素中最重要的似乎是疾病的发病年龄、受累程度、疾病进展的速度,特别是肝脏、肺和造血系统等关键器官系统是否存在功能障碍。显然需要进一步研究组织学特征和免疫学发现的意义,以加深我们对这种疾病的理解。

相似文献

1
Prognostic factors in histiocytosis X.组织细胞增多症X的预后因素。
Am J Pediatr Hematol Oncol. 1981 Spring;3(1):57-60.
2
Histiocytosis X. Langerhans' cell histiocytosis.组织细胞增多症X。朗格汉斯细胞组织细胞增多症。
Hematol Oncol Clin North Am. 1987 Dec;1(4):737-51.
3
Langerhans cell histiocytosis in children less than 2 years of age.2岁以下儿童的朗格汉斯细胞组织细胞增多症。
Indian Pediatr. 1999 Jan;36(1):29-36.
4
[Prognostic factors in histiocytosis X].[组织细胞增多症X的预后因素]
Ann Pediatr (Paris). 1989 Oct;36(8):499-503.
5
Histiocytosis-X in Saudi children.沙特儿童的组织细胞增多症-X
Indian J Cancer. 1991 Jun;28(2):53-60.
6
[Histiocytosis X: historical review and therapeutic prospectives].[组织细胞增多症X:历史回顾与治疗前景]
Pediatr Med Chir. 1984 Mar-Apr;6(2):185-91.
7
Histiocytosis X of the head and neck.头颈部朗格汉斯细胞组织细胞增生症
J Otolaryngol. 1981 Jun;10(3):189-94.
8
Langerhans cell histiocytosis--clinicopathological reappraisal and human leucocyte antigen association.朗格汉斯细胞组织细胞增多症——临床病理重新评估与人类白细胞抗原关联
Br J Dermatol. 1996 Jul;135(1):36-41.
9
[Histiocytosis X--a retrospective analysis of 40 cases with localized or disseminated disease].
Monatsschr Kinderheilkd. 1984 Feb;132(2):88-95.
10
[Langerhans-cell histiocytosis (histiocytosis X) in children].[儿童朗格汉斯细胞组织细胞增多症(组织细胞增多症X)]
Ugeskr Laeger. 1993 Jun 7;155(23):1779-83.

引用本文的文献

1
High risk Langerhans cell histiocytosis in children: the role of salvage in improving the outcome. A single center experience.儿童高危朗格汉斯细胞组织细胞增生症:挽救治疗改善预后的作用。单中心经验。
Orphanet J Rare Dis. 2024 Jun 24;19(1):242. doi: 10.1186/s13023-024-03232-8.
2
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.儿童朗格汉斯细胞组织细胞增生症的临床基因组关联:一项国际队列研究。
Blood Adv. 2023 Feb 28;7(4):664-679. doi: 10.1182/bloodadvances.2022007947.
3
Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement.
成人朗格汉斯细胞组织细胞增生症肺部受累患者的临床表现和预后分析。
BMC Cancer. 2020 Sep 23;20(1):911. doi: 10.1186/s12885-020-07421-z.
4
The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial.甲氨蝶呤联合阿糖胞苷治疗初诊成人朗格汉斯细胞组织细胞增生症:一项前瞻性Ⅱ期干预性临床试验。
BMC Cancer. 2020 May 18;20(1):433. doi: 10.1186/s12885-020-06872-8.
5
A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.一项多中心研究调查了发生继发性噬血细胞性淋巴组织细胞增生症的多系统朗格汉斯细胞组织细胞增生症患者。
Cancer. 2019 Mar 15;125(6):963-971. doi: 10.1002/cncr.31893. Epub 2018 Dec 6.
6
Isolated Langerhans cell histiocytosis of the spleen: A case report.脾脏孤立性朗格汉斯细胞组织细胞增多症:一例报告。
Medicine (Baltimore). 2018 Sep;97(38):e12378. doi: 10.1097/MD.0000000000012378.
7
Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.朗格汉斯细胞组织细胞增多症发病机制的见解:靶向治疗的发展
Immunotargets Ther. 2016 Oct 12;5:81-91. doi: 10.2147/ITT.S91058. eCollection 2016.
8
Bone marrow infiltration in Langerhan's cell histiocytosis - An unusual but important determinant for staging and treatment.朗格汉斯细胞组织细胞增多症中的骨髓浸润——分期及治疗的一个不常见但重要的决定因素
Int J Hematol Oncol Stem Cell Res. 2015 Oct 1;9(4):193-7.
9
Adult onset of multisystem Langerhans cell histiocytosis with skin and lymph node involvement.成人起病的多系统朗格汉斯细胞组织细胞增多症伴皮肤和淋巴结受累。
Postepy Dermatol Alergol. 2015 Jun;32(3):225-8. doi: 10.5114/pdia.2014.40970. Epub 2015 Jun 15.
10
Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?埃及儿童朗格汉斯细胞组织细胞增多症(LCH):复发是否会影响预后?
Indian J Pediatr. 2016 Mar;83(3):214-9. doi: 10.1007/s12098-015-1801-8. Epub 2015 Jul 3.